Content provided in partnership with

Next Closure product approved by FDA

BT Catalyst, Feb-March, 2003

Closure Medical Corp. (Nasdaq: CLSR) of Raleigh recently received approval from the U.S. Food and Drug Administration to market its High Viscosity Dermabond Topical Skin Adhesive.

Most Popular Articles in Technology: An overview of continuous data protection; Why all those current ratings?; Many countries now have a mobile penetration rate above 100%, report says; The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...; MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...; More »

This new thicker form of Dermabond adhesive provides physicians greater precision and control of application, especially when used on curved areas of the body such as around the eyes and nose. The product will be distributed by a division of Ethicon Inc. of Somerville, N.J., a Johnson & Johnson company. Ethicon also distributes Closure's original Dermabond product.

Technology Industry

Next Closure product approved by FDA

BT Catalyst, Feb-March, 2003

Find Research Guides for:

Find Featured Titles for: Arts

Most Popular Articles in Technology

Most Popular Publications in Technology